Citigroup »

Mirati Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Mirati Therapeutics shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Mirati Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mirati Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirati Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.6M 62k 58.76
2023-09-30 $6.9M 158k 43.58
2023-03-31 $6.8M 184k 37.18
2022-12-31 $6.7M 148k 45.31
2022-09-30 $5.2M 79k 66.18
2021-12-31 $5.1M 35k 147.51
2021-03-31 $5.0M 30k 171.24
2020-12-31 $18M 82k 219.55
2020-09-30 $3.4M 21k 165.92
2020-06-30 $7.0M 61k 115.03
2020-03-31 $3.7M 48k 76.90
2019-12-31 $6.7M 52k 128.96
2019-09-30 $4.9M 63k 78.12
2019-06-30 $8.4M 82k 103.00
2019-03-31 $1.7M 24k 72.42
2018-12-31 $6.9M 166k 41.78
2018-09-30 $2.9M 62k 47.10
2018-06-30 $1.2M 25k 49.31
2018-03-31 $818k 27k 30.71
2017-12-31 $758k 42k 18.25
2017-06-30 $0 1 0.00
2017-03-31 $999 225 4.44
2016-12-31 $1.0k 200 5.00
2016-09-30 $1.0k 191 5.24
2016-06-30 $3.0k 591 5.08
2015-12-31 $166k 5.2k 31.65
2015-09-30 $12M 342k 34.43
2015-06-30 $75k 2.4k 31.18
2014-09-30 $4.0k 250 16.00
2014-03-31 $999 29 34.48